Advanced therapies, hospital exemptions & marketing authorizations: the UK's emerging regulatory framework for point-of-care manufacture (2023)
Attributed to:
FUTURE TARGETED HEALTHCARE MANUFACTURING HUB
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Volume: 9
Parent Publication: Cell & Gene Therapy Insights
Issue: 1